225.45
price up icon1.38%   3.06
after-market Handel nachbörslich: 225.45
loading

Warum fällt Becton Dickinson Co-Aktie (BDX)?

Wir haben während der Handelssitzung 2024-11-07 einen Rückgang der Aktie Becton Dickinson Co (BDX) um 5.39% festgestellt. Obwohl dies auf normale Volatilität oder verschiedene interne und externe Faktoren zurückzuführen sein kann, beachten Sie bitte, dass wir die Situation aktiv beobachten und so schnell wie möglich zeitnahe Updates bereitstellen!
2023-11-09:

Shares of Becton Dickinson And Company (BDX) dropped by 9.25% from $255.92 to $232.24 in the trading on Thursday, Novemeber 9, 2023. The reasons why BDX down include:

  • Mixed Q4 Earnings: BD reported adjusted earnings per share (EPS) of $3.42 for Q4 2023, marking a 24.4% year-over-year increase. However, this figure was in line with analyst expectations, leading to mixed sentiment. The full-year adjusted EPS of $12.21 represented a 7.6% increase compared to the previous fiscal year but slightly missed the consensus estimate. BD's Q4 2023 revenues were $5.09 billion, surpassing expectations and showing a 6.8% year-over-year growth. Full-year revenues also exceeded estimates. BD's various business segments, including BD Medical, BD Life Sciences, and BD Interventional, reported revenue performances in line with or slightly below analysts' estimates.
  • Concerns about margin contraction: BD's gross profit decreased by 18.1% in Q4, with a significant gross margin contraction of 1017 basis points. Operating profit and margin also saw declines.
  • Disappointing FY2024 Guidance: BD provided its fiscal 2024 outlook, with projected revenues, organic revenue growth, and adjusted EPS falling within the range of analyst expectations.
medical_instruments_supplies ALC
$85.57
price up icon 0.08%
medical_instruments_supplies RMD
$243.60
price up icon 0.85%
medical_instruments_supplies WST
$320.88
price up icon 2.96%
medical_instruments_supplies COO
$99.91
price up icon 0.84%
$78.72
price up icon 0.87%
Kapitalisierung:     |  Volumen (24h):